Nephros Inc (NEPH)
2.09
-0.01
(-0.48%)
USD |
NASDAQ |
Apr 22, 16:00
Nephros Enterprise Value: 17.73M for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 17.73M |
| April 19, 2024 | 17.83M |
| April 18, 2024 | 17.10M |
| April 17, 2024 | 16.68M |
| April 16, 2024 | 17.10M |
| April 15, 2024 | 16.78M |
| April 12, 2024 | 16.78M |
| April 11, 2024 | 16.78M |
| April 10, 2024 | 18.05M |
| April 09, 2024 | 18.78M |
| April 08, 2024 | 18.36M |
| April 05, 2024 | 18.68M |
| April 04, 2024 | 18.57M |
| April 03, 2024 | 18.89M |
| April 02, 2024 | 18.89M |
| April 01, 2024 | 18.89M |
| March 28, 2024 | 18.78M |
| March 27, 2024 | 19.63M |
| March 26, 2024 | 18.99M |
| March 25, 2024 | 18.68M |
| March 22, 2024 | 20.68M |
| March 21, 2024 | 18.99M |
| March 20, 2024 | 18.99M |
| March 19, 2024 | 18.47M |
| March 18, 2024 | 17.94M |
| Date | Value |
|---|---|
| March 15, 2024 | 18.57M |
| March 14, 2024 | 18.47M |
| March 13, 2024 | 19.52M |
| March 12, 2024 | 20.15M |
| March 11, 2024 | 21.42M |
| March 08, 2024 | 24.16M |
| March 07, 2024 | 27.54M |
| March 06, 2024 | 28.38M |
| March 05, 2024 | 27.43M |
| March 04, 2024 | 27.01M |
| March 01, 2024 | 28.27M |
| February 29, 2024 | 29.01M |
| February 28, 2024 | 28.38M |
| February 27, 2024 | 31.01M |
| February 26, 2024 | 32.12M |
| February 23, 2024 | 34.92M |
| February 22, 2024 | 33.02M |
| February 21, 2024 | 32.60M |
| February 20, 2024 | 32.65M |
| February 16, 2024 | 32.73M |
| February 15, 2024 | 32.70M |
| February 14, 2024 | 32.60M |
| February 13, 2024 | 32.62M |
| February 12, 2024 | 32.60M |
| February 09, 2024 | 33.33M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
7.382M
Minimum
Mar 31 2023
101.82M
Maximum
Jun 29 2021
45.52M
Average
47.72M
Median
Jan 18 2022
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 890.47M |
| Retractable Technologies Inc | -13.49M |
| Xtant Medical Holdings Inc | 125.46M |
| Asensus Surgical Inc | 46.93M |
| Catheter Precision Inc | -0.0108M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.654M |
| Revenue (Quarterly) | 3.254M |
| Total Expenses (Quarterly) | 3.903M |
| EPS Diluted (Quarterly) | -0.06 |
| Gross Profit Margin (Quarterly) | 62.11% |
| Profit Margin (Quarterly) | -20.10% |
| Earnings Yield | -7.18% |
| Normalized Earnings Yield | -7.177 |